Gregg Gilbert

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Gregg Gilbert works at BAML and is focused on the Healthcare sector with 463 price targets and ratings documented since 2013 spanning on 25 stocks. Previously, Gregg Gilbert worked at TRUIST, DEUTSCHE BANK. Analyst's average stock valuation to be materialised ratio is 66.16% with an average time for price targets to be met of 284.16 days.

Most recent stock forecast was given on ATRS, Antares Pharma, Inc at 13-Apr-2022.

Gregg Gilbert best performing recommendations are on LCI (LANNETT COMPANY, INC).
The best stock recommendation documented was for LCI (LANNETT COMPANY, INC) at 8/29/2019. The price target of $40 was fulfilled within 1 day with a profit of $4.48 (12.61%) receiving and performance score of 126.13.

Average potential price target upside

of $34.84 (54.98%) on LGND (LIGAND PHARMACEUTICALS INCORPORATED).
of $28.77 (16.01%) on AGN.
of $27.3 (20.73%) on JAZZ (JAZZ PHARMACEUTICALS PLC).

Currently, out of the existing stock ratings of Gregg Gilbert - 22372 which are a Buy (67.95%), 10284 which are a Hold (31.24%), 267 which are a Sell (0.81%)